Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis: Carbonic Anhydrase Inhibitors as Antithrombotics

Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis: Carbonic Anhydrase Inhibitors as Antithrombotics

Carbonic anhydrase (CA) inhibitors have a long history of safe clinical use as mild diuretics, in the treatment of glaucoma and for altitude sickness prevention. In this study, we aimed to determine if CA inhibition may be an alternative approach to control thrombosis. We utilized a high-resolution...

Full description

Bibliographic Details
Main Authors: Ejaife O. Agbani, Xiaojuan Zhao, Christopher M. Williams, Riyaad Aungraheeta, Ingeborg Hers, Erik R. Swenson, Alastair W. Poole
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Platelets
Subjects:
acetazolamide
carbonic anhydrase
methazolamide
platelets procoagulant membrane dynamics
Online Access:http://dx.doi.org/10.1080/09537104.2019.1709632

Internet

http://dx.doi.org/10.1080/09537104.2019.1709632

Similar Items